Welcome to our dedicated page for Brookdale Senior SEC filings (Ticker: BKDT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Brookdale Senior's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Brookdale Senior's regulatory disclosures and financial reporting.
Brookdale Senior Living Inc. (symbol: BKDT) Form 144 filing discloses the intended sale of 165,370 common shares on or about 10 July 2025 through UBS Financial Services. The shares have an aggregate market value of roughly $1.24 million, versus 234.3 million shares outstanding, equating to about 0.07 % of total shares.
The seller – listed as Lucinda Baier – has already completed seven transactions in the past three months, disposing of 737,316 shares for gross proceeds of ≈ $5.09 million. Adding the new notice, cumulative planned and completed sales reach 902,686 shares, or roughly 0.39 % of shares outstanding.
Under Rule 144, the filer certifies no undisclosed material adverse information and affirms compliance with volume and manner-of-sale limitations. No details are provided on relationship to the issuer or use of proceeds.
Brookdale Senior Living Inc. (ticker: BKDT) has filed a Form 144 indicating a proposed sale of up to 25,000 shares of its common stock through Charles Schwab & Co. on or about July 10, 2025. The aggregate market value of the planned sale is $186,375, compared with approximately 234.35 million shares outstanding, representing roughly 0.01 % of the public float.
The shares were originally acquired on May 20, 2011 via an equity-compensation transaction described as “Services Rendered.” No other sales by the same holder were reported during the past three months. The filer affirms that no undisclosed material adverse information is known and acknowledges the legal attestations associated with Rule 144.
Given the modest size relative to the company’s share base and the lack of accompanying negative disclosures, the filing appears routine and is unlikely to have a material impact on Brookdale’s capital structure or near-term share-price dynamics.
FAQ
What is the current stock price of Brookdale Senior (BKDT)?
